Improved Harm/Benefit Ratio and Cost-effectiveness of Prostate Cancer Screening Using New Technologies. Heijnsdijk EAM, de Koning HJ. Eur Urol 2022 Feb 4. pii: S0302-2838(22)00075.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Heijnsdijk EAM, de Koning HJ. Improved Harm/Benefit Ratio and Cost-effectiveness of Prostate Cancer Screening Using New Technologies. Eur Urol 2022 Feb 4. pii: S0302-2838(22)00075.
PMID: 35131116